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Objectives. We sought o validate ailh coronary angiogmphy 
several primary and ancillvy markers of reperfusion. 
Background. The availability of bedside markers of reperlu. 
sioo b of majw importance in the thrcmbotytic therapy of acute 
myaeardial infarction. However. the reliability of current mnrk- 
err is still c~otroversiat. 
~Welhods. Changes in cbet pain, ST segment elevation and 
heart rate and rhythm were assessed every 5 to IO min for uo to 
3 h after initialion of recorobinant tissue-type plasminogen acti- 
vator therapy in 82 patients with acute myocardiil infarction. 
Coronary ansiography was performed within 24 h. 
ResusuL. At angiogapby, 69 of the 82 patients bad a patent 
iniarct.relatednrtery nlth Thmmbolysis n Myoawdinl b&&n 
trial (TIMI) ~pde 3 flow and B rapid and prugwssive decrease in
chert patn and ST okvation. Tbe pain rosolred in 24 ? 23 min 
tnop 3 to So). The ST olevalirn %wasfd by a509 Hitbin 16 f 
14 min (range 5 to 41). Accelerated idioventticular hythm 
developed in 49% of p&tents and sinus bradycnrdia in 23%: 
cwductbm rbnommlitii and atrial fibriltatiin resolved. All 
markers appeared in close temporal pmxtmity to the onset of an 
abrupt increase in ma creatine khwe (CK) and C&MB 
isoenzyme aaivity, a previously validated marker of Ibe time of 
reprfuion. Before its &at rwt&oa, ST ekmtica brnMoUy 
decreased and increased tn 58% of patit&. Caqwisw af one 
pretreatment and one pmtbatwnt 
eantty redured the r&biMy &ST vgomtt 
reperlhsion. 
TIM1 grade ri flow; ia 9, pain and SC &vat& did not kswa 
and CK and UC-MB activity sbowd w abrapt inci-eae. Tiw 
and ST ekrstion; however, &bin 3 band b&we Y, 
elevation is n retiik marker ef rqerfusia with grade 3 
flow. Boeause ST elevation aad pak~ often Rwhwde b&we urder- 
going Bnal reol~tkm with qw‘usion, freqw& 
mwdloring of ST ekvatbm is ssontial for relkbk 
the fact and tbnc ot rq.uf&a. Ace&a&d 
rhythm and epiwds of sudden siaaF bnrlyeardkx, 
specific to reperfusbm, do not occur in all p&&s with rrprht- 
Siam. 
(I Am Coil Car&d 1993;21:5%51) 
Although early coronary angiogmphy has been considered 
the reference standard for the diagnosis of reperfusion, its 
widespread and routine application immediately afteradmin- 
istration of thrombalytic therapy is associated with a risk of 
periaccess bleeding and is logistically difficult and costly. 
Thus, the bedside recognition of reperfusion would allow 
alternative therapy and selective application of additional 
invasive interventions only in those patients who fail to 
demonstrate signs of reperfusion. thereby avoiding the need 
for mutine immediate angiography for all patients. Although 
some of the bedside markers of reperfusion. such as apid 
relief of chest pain, rapid decrease in ST segment elevation 
and occurrence of accelerated idioverdricular rhythm. have 
been known since the earllv days of thrombalvtic therapy 
(1.2). their routine use has.&; delayed by the results~~f 
sewal studies G-5) that have suestioned their validitv. 
The purpose of this study 6s to prospectively v&date 
the value of several bedside marken of reperfusion. using 
early coronary angiogmphy as the reference standard. In 
addition, we used an abrupt increase in plasma crealine 
kinase (CK) and CK-MB iswozyme activity a~ a marker for 
the timing of repertitsion because this event was demon- 
strated in our inhacoronary streptokinase study (6) to coin- 
cide with angiogmphic evideoce of reperfosion. 
Me&ads 
Study patients. The study was conducted in 82 conwu- 
tive patients with acute myccardial infarction receiving 
recombinant !isrue-type plasminogen activator (rt-P.A). The 
protocol was approved by the Institutional Review Board of 
The Cedars-Sinai Medical Center. Table I summarizes the 
clinical characteristics of the study patients. From the orig- 
inal cohort of 86 patients, 4 were excluded (2 who died 
within 2 h of the onsei of treatment and thus did not undergo 
attgiography and 2 who did not have a confirmed diagnosis of 
acute myocardial infarction). Patients with acute myocardial 
infarction were candidates for inclusion in the study if they 
had chest pain of <4-h duration, ST segment elevation in at 
least two contiguous leads, were -Z76 years old and had no 
contraindication to thrombolytic therapy. 
Study design. Recombinant tissue-type plasminogen ac- 
tivator was given in a dose of 150 mg over 2 h to the first 42 
patients and in a dose of 100 mg over 2 h to tbe last 40 
patients. Before the initiation of tbrombolytic therapy, pa- 
tients received a 40.Uikg bdus dose of intravenous heparin, 
followed by an infusion at a rate of IO to 12 U/kg per h that 
was adjusted to maintain the partial thromboplastin time 
between 60 and 80 s. If no intervention such as coronary 
angioplasty or coronary artery bypass surgery was per- 
formed, the infusion ofheparin was continued for 3 to 5 days 
and was followed by maintenance with oral warfarin for 2 
months. As part of the investigational protocol, coronary 
angiograpby was performed within 24 h an average of I4 2 
IO h (range 2 to 24) after the start of thrombolytic therapy. 
The angiogmphic results were assessed by experienced 
attgiographers not involved in the study, using the classifi- 
cation of the Thrombolysis in Myocardial Infarction (TIMI) 
Study Group (7). The time of aogiography varied with the 
time of the day and according to the availability of the 
cardiac catheterization laboratory and was not dependent on 
the sttcce~~ or failure of repetfttsion. During the conduct of 
thrombolytic therapy, two of the investigators were always 
present at the bedside to observe and document the follow- 
ing markers of reperfusion. 
Charges in ST segmenr elevarion. A standard 12.lead 
electrocardiogram (ECG) with a Marquette Electronics elec- 
trocardiograph was recorded on admission and again just 
before the initiation of thrombolytic Iherapy. A lead with 
distinct ST segment elevation was selected for continuous 
monitoring. During and, if necessary, after thrombolytic 
therapy, leads 1 to II1 in patients with inferior infarction and 
leads Vt to V, or V, to V6 (whichever had the higher ST 
elevation) in patients with anterior infarction were recorded 
at 5- to IO-min intervals and when a change in chest pain, 
rhythm or heart ratc was noted. The magnitude of ST 
segment elevation was measured 40 or 80 ms after the I 
point, at the same point in a given patient. 
Changes in chest pain. Before the initiation of thmmbo- 
lytic therapy, the patients were asked to grade their chest 
pain on a scale of 0 to 10 (0 = no pain; IO = worst pain) and 
to immediately report any change in the intensity of pain. 
Occurrence of accelerated idioventricular rhythm. When 
a change in rhythm was observed on the monitor, it was 
immediately recoided. The time of the appearance of accel- 
orated idioventriculsr rhythm was noted and the arrhythmia 
recorded. Accelerated idioventricular hythm was defined as 
three or more consecutive ventricular ectopic beats at a 
reaular rate of =I00 beat&tin. beainnina with a loop. coo- 
pling interval. 
_ _ 
Changes in hear1 rare. Episodes of sudden sinus brady- 
cardia at a rate of ~50 beatslmin were noted and recorded. 
Changes in conduction abnormality. Patients presenting 
with atrioventricular (AV) or intraventricular block were 
observed to determine whether and when the block re- 
solved. 
Conversion of orriolfibrillafion fo sinus rhythm. Patients 
presenting with atrial fibrillation as a complication of acute 
myocardial infarction were observed to determine whether 
and when atrial fibrillation converted to normal sinus 
rhythm. 
Plosmo CK and CLUB activity. Blood samples for CK 
and CK-MB measurement were taken at 30.min intervals in 
the 1st 3 h and then every I to 4 h for up to 24 h. Blood was 
collected into tubes containing ethyleneglycol-bis-(beta- 
aminoethyl ether)N,N’-tettaacetic acid (EGTA) (final con- 
centration IO mmollliter). The plasma was harvested and 
total CK measured by the method of Rosalki (8) using 
Worthington reagents. The CK-MB activity was analyzed 
after separation of the &enzymes on column chmmatogra- 
phy. The upper limits of normal for these measurements 
were 70 and 5 IUniter for plasma CK and CK-MB. respec- 
tively. Two 24-h time-activity carves were plotted from the 
CK and CK-MB values. From these curves, the rate of rise 
of CK and CK-MB activity in the tst h of rise was deter- 
mined and expressed as a percent of the peak rise. The 1st h 
of rise was determined from the ditTerence of the first 
elevated value and the last baseline value or the difference 
between the second and first elevated values (6). 
Statistk~J wRtods. The data are presented as mean value 
* SD. Continuous variables were analyzed with an unpaired 
I tett and categoric variables were analyzed by using the 
Fisher exact test or the chi-square test. A p value < 0.05 was 
considered significant. 
Results 
Coronsrv anaiwtrad~v. Coronarv anaiaaraohv showed a 
patent iofa&-r&&d’ariery with TiMI glade j &w in 69 of 
the 82 oatiettts. Of the remainine 13 aatients. 8 had a totallv 
occlttdkd infarct-related artezy, i had’TIM1 &e 1 Bow ad 
2 had TIM1 grade 2 flow. 
Patkttts with TIMI grade 3 &IV. In 4 of the 69 patients, 
both the chest pain and ST segment elevation resolved by 
the time thrombolytic therapy war initiated. In two of these 
four patients. plasma CK and CK-MB activity was elevated 
Figure 1. Time course ofST segment elevation m a selected kad in 
a Patient (pt.1 with manifestations fspontaneous repcrfusicn. From 
the time of admission (A) to the time of initiation of thrombolytic 
therapy Rime 0): both the chest pain (CP) and ST segment elevation 
had markedly rmpmved. The plasma crcatine kinase ICKI and 
CK-MB activities wcrc elrvatcd t 11 and increasing before throm- 
bolytic therapy was begun (I mm of ST ekvatian = 0.: mV). 
and already increasing before the initiation of thrombol!rtic 
therapy. We believe that in these four patients. the infarct- 
related artery “spontaneously” rep&wed (Fig. 11. In the 
remaining 65 patients. the ST segment elevation and chest 
pain persisted and plasma CK and CK-MB activity was not 
increasing at the start of thrombolytic Therapy, suggesting 
stable occlusion of the infarct-related artery. All 65 patients 
subsequently manifested the following signs of repeffusion. 
Rnpidandprogressive decrease in STsegmenf elevntion. 
This began an average of 48 ? 28 min after the initiation of 
thmmholytic therapy (Fig. 2). Becfnw the ST segment 
returned to the isoelectric baseline during the period of 
observation in only 27% of patients (19% with anterior 
infarction and 36% with inferior infarction. p = 0.11, the rate 
Figure 2. Time course of ST ~egrnent e evalion in a sclccted lead 
frnm a patient (pt.) who bad a marked increase in ST segment 
elevation between the time of admission IA) and the time of 
initiation of thmmbolytic therapy (time 0). During thmmbolytic 
therapy. ST segment elevation was relatively stable fur I5 min. 
when the ST segment elevation began to decrease rapidly and 
progressively along with a rapid decrease IU) in chest pain (CPI. 
Accelerated i iovenlricular rhythm (ANN npparcd minutes later 
and there was a near rimultanwua brupt increase ( 1 i in plasma 
creatine kinare (CK) activity. The marked increase in ST segment 
elevation between the time of admission and the initiation of 
thmmbolytic therapy further drxumenrs the paential for serious 
error if conclusions regarding rcperfusion are made from only two 
ekctrocardiograms (one on admission and one at a fixed time. for 
example. W min after initiation of thmmbolylic therapy). 
Figure 3. The typical Ructuation in ST segment elevation in a 
xlected lead fmm a patient (Pt.) during tbrombolytic therapy. with 
worsening, improvement and funher wnrscuing minutes before the 
stan of the final rappid and progressive r sub~ion. Changes in chest 
pain (CP) paralleled the changes in ST segment ekvation and chest 
pain was completely rez&ed in 12 min (CP = 0). The onset nfthe 
final resdu:ion of chest pain and ST segmenr elevation began witbin 
minutes of the abrupt increase in plasma erealke kimse (CK) 
activity. A = admission; r = increase: fl = large iweasc; 1 = 
decrease: 11 = large decrease. 
of decrease was measured as the time interval from the onset 
of the final decrease to a >SO% decrease in ST segment 
elevation. This averaged I6 2 14 min (range 5 to 41). 
Rapid and progressive resolution of chesr pain. This 
began an average of 51 + 20 min after the initialinn of 
therapy. The time interval from the onset of a progressive 
decrease to complete resolution of chest pain averaged 24 + 
23 min tnngc 3 to SOL The final and progressive resolution of 
chest pain rmd ST segment elevaticm was preceded by a 
transient fluctuation (improvement or worsening, orb&) in 
37 patients (57%) (Fig. 3). In eight of these patients, the 
““set of final resolution was immediitely preceded by a 
marked worsening of both the chest pain and ST segment 
elevstio” (Fig. 4). 
In patients in whom a decrease in ST segment elevation 
and chest pain suggested reperfusion within W min of the 
initiation of thmmbolytic therapy, we also explored the 
feasibility of recognizing reperfusion by comparing the ST 
segment elevation on only IWO EC& one recorded before 
and the other reforded 90 min after the initiatian of thmm- 
bolytic therapy. In 7 (11%) of the 65 patients. ST segment 
elevation at 90 min was either identical or higher than that 
before treatment, erroneously suggesting failure of reperfu- 
sion. This apparent discrepancy was caused by a” increase 
iu the ST segment elevation above the pretreatment level 
during thnmbolytic therapy and the onset of resolution of 
ST segment elevation from this higher level (Fig. S). Fur- 
thermore. in 2 of the 65 patients. in whom ST segment 
resolution began >90 min after the initiation of thrombnlytic 
therapy, the occurrence of repwfitsian would have been 
missed if only a single ECG had been recorded 90 min after 
the start of therapy. Thus, frequent sampling of the ST 
segment correctly identified repzfurion in all 69 patients, 
whereas comparison of a single pretreatment ECG with a 
Figure 4. The dramatic wwscning of the ST segment elevation in a 
selected lead in a patient during thrombolytic therapy just minutes 
befox th; ozct of the final rapid and progressive resolution. 
Chants in chest pain (CP) paralleled changes in ST segment 
elevation, with complete relief (CP = 0) occurring in IS min. The 
plasma creatine kinase (CKl activity increased : t ) abruptly, coin- 
cident with the omet of progressive resolu:ion of ST segment 
elevation and chest pain. Abbreviations 8s in Figure 3. 
single %min posttreatment ECG identified only &l(87%) of 
the 69 patients with reperfusion (p < 0.001) and did not 
indicate the time of reperfusion. 
Ancillary markers cd reperfusion. Acceleraled idiovea- 
tricular rhythm. Accelerated idioventricular rhythm ap- 
peared in 32 (49%) of 65 patients with TIMI grade 3 Row at 
an average of42 ? I5 min after the initiation of thrombolytic 
therapy. The frequency of this arrhythmia did not ditfcr 
Figure 5. This figure demonstrates that relying only on an admission 
electrocardiogram tECG) and an ECG recorded at 90 min after the 
initiation of thmmbatytic therapy (time 0) can lead to an erroncou~ 
conclusion about whether or not reperfusion has occurred. The ST 
segment elevation at 90 min alter trcatmcrd is not ditTerent from that 
at admission (A). suggesting lack ofreperfusion. In reality, the ST 
segment fluctuated during thrombolytic therapy. Seventy minutes 
after the initiation of thrombolytic therapy, ST segment elevation 
began to decrease rapidly and progressively fmm a level that was 
higher than at admission and this phenomenon was missed by the 
ringle 90-r& ECG. Reperfusion was F.ISD indicated by a nc~r 
simultaneous resolution ofchest pain (CPI and an abrupt increase in 
plasma creatine kinase (CK) activity. Abbreviations ns in Figure 3. 
significantly between patients with anterior or inferior myo- 
cardial infarction (47% vs. 48%). 
Sudden sinus bradycordia. Episodes of sudden brady- 
cardia (associated with a decrease in systolic blood pressure 
to ~90 mm Hg) occurred in I5 (23%) of the 65 patients at an 
average of 42 2 i8 min after the initiation of thmmbolytic 
therapy. In 14 of these IS patients, the tight coronary artery 
was the artery of infarction; in the remaining patient, the 
repelfused left circumflex coronary artery supplied collateral 
flow to a previously occluded right coronary artev. 
Resolution of coaducrion abnomolity. In five patients 
with AV block and two aatients with rieht bundle branch 
block caused by the acut;infarction. theconduction abnor- 
malities resolved in close temporal proximity to the onset of 
the resolution of ST segment elevation. 
Conversion of atria1 fibrillarion to sinus rhvthm. In one 
patient with at&l fib&&n caused by the act& infarction, 
sinus rhythm returned within minutes of the onset of the final 
resolution of ST segment elevation. 
TemperaI reIalion behveea bedside markem of reperfieion 
and the lime of abnmt Incrpw In dasma CK and CK-MB 
saivtty. in the 65 patients with lIti1 grade 3 flow, plasma 
CK and CK-MB activity increased abruptly by 30 f 14% 
(range 14% to 72%) and 28 t 13% (range 14% to 76%) of the 
maximal increase in the first hour of rise. respectively. This 
prospectively confirms the tinding of our intracoronaty 
streptokinase study (6) that the abrupt enzyme increase is a 
marker of reperfttsion with TIM1 grade 3 Row. The increase 
began at an wetwe of 44 + 20 mitt at&r the initiation of 
thr&nbolytic theraiy and marked the time of reperfusion. 
The onset of the final decrease in ST segment elevation and 
chest pin as well as accelerated idioventricular titythm and 
sinus bradycardia occurred within 30 min of the abrupt CK 
increase in 93% to 95% of patients (Fig. 6). 
Patients with TIMI grade ~Zftow. In9of I3 patients with 
TIM1 grade 52 flow, no signs of reperfusion (mpid and 
progressive decrease in chest pain and ST Segment eleva- 
tion) develooed within 3 h of initiation of thrombolvtic 
therapy (Fig: 7). The rate of rise of plasma CK and CK-hB 
activity was slow, averaging only 2 + 2% (range 0% to 4%) 
and 2 z 2% (range G% to 5%) of the peak rise in the 1st h of 
rise, respectively. At coronary angiography, six patients had 
B totally occluded infarct-related artery, two had TIM1 grade 
I Row and one had TIM1 grade 2 Row. 
The remaining 4 ofthese 13 patients initially showed signs 
of repcrfusion (rapid resolution of chest pain and ST segment 
elevation. as well as a rapid increase in plasma CK and 
CK-MB activity on the 24-h time-activity curve). One of 
these patients also developed a brief episode of accelerated 
idioventricttlar hythm. However, within 3 h, chest paitt and 
ST segment elevation recurred, indicating reocclusion. On 
coronary angiography, the infarct-related artery was totally 
occluded in two of the four patients, had TIMI made I Row 
in one patient and TIMI grade 2 flow in the fourth patient. 
Fire 6. Time course &ST segment elevation in 
lead V, along with the creatine kinase Cl0 time- 
activity curve during thrombolytic therapy. The 
close tempmat relation uf an abrupt increase ( T ) 
in Phna CK activity to the unset of rhe final 
rapid and progressive decrease I I ) in ST ~egmenf 
elevation and chest pain (CP) as well as the 
appearance of accelerated i ioventricular rhythm 
(AIVR) are shown. The marked transiee worsen- 
ing of ST segment elevation just beforr: the unset 
of the fina! resolution in also see”. Ab’oreviationa 
as in Figure 3. 
Discussion 
RqY and p-w raolutiun of ST segnwt elevatioo 
aud chest paiu are markers drepwfusia~. Coronary angiog- 
mphy perfomxd 14 -? 10 h after the initiation of thmmbo- 
Wtic therapy contimted that retwfusion can be recoenized 
by bedside-markers. In the 4 patients with spont&ms 
reperfusion and in 65 of69 patients, a rapid and progressive 
decrease in ST segmenl elevation and chest pain correctly 
predicted a patent infarct-related artery with TIMI grade 3 
tlw. In the remainina four uatients with initial sians of _ . 
reperfasion, the absence of TIM1 mde 3 Row was not 
unexpected because these patients manifested signs of reac- 
elusion before angiography. In nine patients, the absence of 
signs of wetfusion (that is. the absence of rapid and 
progressive resolution of ST segment elevation and chest 
pain) also correctly predicted TlMI grade 52 flow in the 
infarct-related artery. 
The results also confinned the finding of our intracoru- 
Flawc 7. Time course of ST segment elevation in a selected lead 
>I80 mi” after the initiation of thrumbulydc therapy (lime 0) in a 
patient without evidence uf reperfusion. There was no impmvement 
in chest F&I (CP) or ST segment elevation. which in fact tended IO 
worsen. Plasm creatine kinase (CK) and CK-MB activity showed a 
slow rate of rise and there were no ancillary rigns of reperfusinu. 
Abbreviatiuns as in Figure 1. 
nary streptakinase study (6) that an abrupt increase in 
plasma CK and CK-MB activity of ~13% of peak rise in the 
1st h of rise indicates rep&t&n with TIM1 grade 3 Row. 
The close temporal proximity of the onset of the final rapid 
and progressive decrease in chsst pain and ST segment 
elevation to the onset of rapid enzyme increase corruborates 
the value of these markers for the timing of reperfusion. The 
&se tempwa! proximity of the onset at both the resolution 
of ST segment elevation and chest pain to the onset of abrupt 
enzyme increase is “at surprising because these are all 
consequences of repettusion. resulting in both termination of 
myocardial ischemia and washout of accumulated mywar- 
dial enzymes. The less than pert&t tempmal concordance of 
theonsetoftheseeventrcanbeexplainedbythedifferences 
in the timing and time intervals in the acquisition of the ST 
segment. chest pain and CK and CK-MB data. Other inves- 
tigators (Q-12\ have since observed the occurrence of an 
abrupt enzyme increase with repxfusion. 
tlow can *a diuHentiate the rewluliun of Sr segment 
elevation aad cbesl @a omscd by re@u+iun frum char&s 
associated with UC nahwal evulutiun of acute myuwdial 
i&w&n? Changes in ST segment elevation after rep&u- 
sion usually occur earlier and have a mure rapid ccuuse than 
do changes associated with the matural evolution of acute 
myocardial infarction. Accxding to Van Essen et al. (13). 
the decrease in ST segment elevation after reperfusion is 
about five times faster than the rate of decrease associated 
with the natural evoltttian of myucardial infarction. Mare- 
over, reperfusion-induced changes in ST segment elevation 
and chest pain are accompanied by otiw signs OF reperfu- 
sion, such as reperfuaio” arrhythmias and episodes of sud- 
den sinus bradywdia. as well as other signs of termination 
of myocardial ischemia. such as resolution of conduction 
abnormalities and termination of atrial fibrillation. 
How ~811 we recmuik our cottciusion that rapid damease ia 
ST seernerd elenliua is a reliable bedside marker uf reoerfu- 
sian &h the motradictury experience and mndusi~ of 
markers such as accelerated idioventricular rhythm and 
sodden sinus bradycardia are not present in all patients with 
TiMI grade 3 flow. When present, however, they cormhc- 
rate the diagnosis of reperfusion. In general, these findings 
are comparable to the experience of others (27-30). 
Practical implications. On the basis of our findings and 
clinical experience, we suggest the following guidelines for 
recognition of reperfosion during the conduct of thromho- 
lyticiherapy for &ate mywardial infarction. A Il-lead ECG 
should he recorded immediatelv before the initiation of 
thrombolytic therapy. A lead &ith distinct ST segment 
elevation should be selected for continuous monitoring. 
Short strips of this monitored lead should be recorded at 5. 
to IO-min’intervals until stable rep&i&ion is indicated by a 
progressive and rapid decrease in ST segment elevation or a 
decision is made to employ alternative therapeutic interven- 
tions to achieve reps&ion. In our experience, reperfusion 
can he exaected within 2.5 h after the administration of&PA 
and up td4 h after the administration of streptokinase. The 
presence of a trained nurse at the bedside of a patient 
undergoing thrombolytic therapy not only will increase the 
safety of the procedure, but alw will facilitate the collection 
of necessary data for the recognition of repefision. 
others? There itle several potential explanations for the 
dlerences in results and conclusions. First, we assessed 
changes in the ST segment at 5- to 1Omin intervals rather 
than at two fixed points in time as was done by others 
(3-5,14,15). This ditference is extremely important because 
during thrombolytic therapy, both the magnitude of ST 
segment elevation and the severity of chest pain show 
significant fluctuations oramarked worseningjust before the 
onset of their final and progressive resolution in >5G% of 
patients (Fig. 3 and 4). As aconsequence, the final resolution 
often begins from levels of ST segment elevation and chest 
pain that are significantly higher than pre.treatment levels. 
When ST segment elevation and chest pain are compared 
before treatment and at a fixed interval after the initiation of 
therapy, comparison of only the two levels may lead to the 
erroneous conclusion that there is no improvement and, 
hence. no reperfuion or that there is significant improve- 
ment and reperfusion has occurred (Fig. 5). In 11% of our 
patients ST segment elevation recorded at 90 min after the 
initiation of thrombolytic therapy was similar to or higher 
than that recorded before thrombulytic therapy, when in fact 
it was rapidly decreasing as a consequence of reperfusion 
IFia. 5). Furthermore. wmoarison of the ECGs recorded at 
ihe& hvo times would have missed the two cases of reper- 
fusion that occurred after 90 min. Our conclusion that 
reperfosion can he reliably recognized at the bedside is 
supported by other investigators (16-19) who also used 
frequent or continuous monitoring of ST segment changes. 
The fluctuations in the ST segment are probably doe to 
fluctuations in the patency of the infarct-related artery, as 
has been observed in other studies (20-22). 
Second, the use of identical. less than optimal ECG leads 
(for example, leads II and VJ regardless of infarct location 
may also have led to erroneous conclusions in previous 
studies (5). 
Third, in another study (231, the interval between the time 
of thrombolytic therapy when ST segment changes were 
assessed and the time of coronary angiography when the 
status of the infarct-related artery was ascertained was too 
long to reliably reflect the states of the artery at the time of 
treatment. 
Fourth, the inclusion of patients with TIM1 grade 2 flow 
in the category of repelfusion may have been yet another 
source of discrepancy (5). The sluggish TIM1 grade 2 flow 
does not produce reperfusion arrhythmias, an abrupt in- 
crease in plasma CK and CK-MB activity or a distinct 
improvement in ST segment elevation and chest pain (6). 
The inability of bedside markers to differentiate patients with 
TIM1 grade 2 flow fmm those with TIM1 grade 0 or I flow is 
not necessarily adrawback because went data (24-26) have 
shown that with TIM1 grade 2 flow, the infarot-related artery 
behaves clinically more like an occluded artery, with no 
benefit in terms of ventricular functiun or mortality. 
Ancillary markers of reperfusioa. Although the rapid 
resolution of ST segment elevation and chest pain (when 
present) are definitive markers of reperfusion, ancillary 
Conclusions. Using coronary angiogmphy as our refer- 
ence standard in 82 patients with acate myooardial infarc- 
tion, we confirmed that the rapid and progressive decrease in 
ST segment elevation and the rapid relief of chest pain, when 
pain is present at the start of thmmbolytic therapy, are 
definite markers of reperfosion with TIM1 grade 3 flow. 
When present, ancillary markers of rep&&ion, such as 
accelerated idioventricolar rhythm, sodden sinus bradycar- 
dia, resolution of conduction abnormalities and conversion 
of atrial fibrillation, help to corroborate the diagnosis of 
reperfusion. Because ST segment elevation frequently and 
significantly fluctuates or worsens before final resolution 
begins with reperfusion, an erroneous conclusion can be 
made if only a single ECG is recorded at that time. Frequent 
or continuous monitoring ind recording of the ST segment 
changes are essential for reliable recognition of the time and 
fact of reparfusion. 
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